Will price controls hobble Indian pharma innovation?

 drug price controlsMerrill Matthews of the Institute for Policy Innovation thinks the Indian government's recent decision to place antibiotics and over 300 "fundamental" pharma products under price control, will hamper Indian pharma's development. -AMS

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments